| Autor: |
Ufuk Çobanoğlu, Remzi Kızıltan, Özgür Kemik |
| Jazyk: |
angličtina |
| Rok vydání: |
2017 |
| Předmět: |
|
| Zdroj: |
Van Tıp Dergisi, Vol 24, Iss 4, Pp 397-403 (2017) |
| Druh dokumentu: |
article |
| ISSN: |
2587-0351 |
| DOI: |
10.5505/vtd.2017.96967 |
| Popis: |
Malignant pleural effusions are characterized by malignant cells in pleural fluid and appear in the course of various cancers. MPE (Malignant Pleural Effusion) develops during the course of approximately 75% of cases with lung, breast, ovarian cancer, and lymphoma. Its presence indicates that the underlying disease is advanced or widespread. In MPE the average survival is 3-12 months and varies by the cellular type of the underlying malignancy. Among various malignancies, ovarian cancer is associated with the longest survival and lung cancer with the shortest. The most widely accepted mechanism for the mechanism of development of MPE is increased pleural permeability and impaired drainage caused by metastatic disease. In addition to radiological examinations, cytological examination of pleural fluid and closed or open pleura biopsies are the diagnostic tools used for MPE. Treatment is aimed at controlling symptoms and increasing quality of life rather than treating the primary disease. In order to reduce intrapleural fluid volume, control associated symptoms, and improve quality of life and survival, it is imperative to identify the etiology of effusion and to individualize patient management. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
